TP53 and cancer: Recent research indicated cancer as an aggregation disease, the destabilized p53 mutant induced misfolding and co-aggregation of wild-type p53, p63 and p73 into cellular inclusions, and lead to inefficiency of target genes that control cell growth [53,54].